Biotechnology company Hologic Inc. announced a repurchase program for its common stocks worth USD250 million. Under said program, it will be allowed to buy back shares of its stocks in open markets and privately negotiated transactions.
Bio Tech
LoneStar Heart raises USD2.4 million in Series C funding
California-based biomedical firm LoneStar Heart Inc raised almost USD2.4 million in a Series C financing round from unnamed venture investors, which would be used for the company's heart therapies for advanced heart failure patients.
Belgian biotechnology company sells drug discovery unit for EUR25 million
Brussels-based biotechnology company IBA concluded the sale of its drug discovery business unit to private equity firm Argos Soditic. IBA raised EUR25 million from the sale of Cisbio Bioassays.
Temasek exits stake in Facebook, Monsanto and Air Products & Chemicals
Singaporean investment firm Temasek divested its holdings in US-listed companies Facebook, Monsanto and Air Products & Chemicals. The private equity firm, however, remains focused on energy, healthcare and technology stocks in the US.
Yuri Milner invests millions into GenapSys
Russian millionaire and entrepreneur Yuri Milner recently led a Series B funding round for genetics upstart GenapSys for the commercialization of the company's genome-sequencing platform.
Latest News
Connecticut-based Cara Therapeutics Inc. announced its recent filing with the SEC about the proposed initial public offering of the biotechnology company's common stock.
The USD4.2 billion purchase by Shire Plc of ViroPharma Inc is the highest purchase on EBITDA rates for a biotechnology firm in history, as the price is 58 times EBITDA.
Assam Chief Minister Tarun Gogoi, in a press conference, discussed the construction of a cancer and surgical cleft center in his state with the help of private entities.
Many private equity firms and partnerships are in the process of formulating their bids for diagnostic unit of Johnson&Johnson.
An announcement made last Thursday of a realignment in priority drug research projects prompted Citi analyst to advise shareholders of a possible interest divestment in diabetes drug joint venture between Bristol-Myers Squibb and AstraZeneca.
Lion Biotechnologies sold common stock, common stock warrants and Series A Convertible Preferred Stock to institutional investors led by Quogue Capital LLC.
Brussels had launched a full state investigation on the joint venture between Solvay and Ineos due to antitrust concerns.
Midatech's unique biocompatible gold-nanoparticles raised GBP10 million from investors. One of the global leaders in nanomedicine design, synthesis and manufacturing, Midatech Ltd, announced the completion of the issuance of its new equity.
PurThread Technologies, a textile company which had pioneered the technology to reduce bacteria in textile fibers, received over USD7 million in funding led by board chairman Richard Bodman.
